| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/03/2006 | US20060172301 Secreted acid phosphatse (sapm) is present only in pathogenic mycobacteria and expressed selectively at phagosomal ph |
| 08/03/2006 | US20060172298 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/03/2006 | US20060172296 Novel gene associated with rheumatoid arthritis |
| 08/03/2006 | US20060172290 Nucleic acids coding for a protein interacting with a porin channel |
| 08/03/2006 | US20060172287 Murine calicivirus |
| 08/03/2006 | US20060171965 Fusion proteins of mycobacterium tuberculosis |
| 08/03/2006 | US20060171953 Tumour-specific animal proteins |
| 08/03/2006 | US20060171947 Serine/threonine hydrolase proteins and screening assays |
| 08/03/2006 | US20060171942 Modified fusion molecules for treatment of allergic disease |
| 08/03/2006 | US20060171940 Antibody disulfide isomers, use thereof, and methods of analyzing same |
| 08/03/2006 | US20060171884 Provide a higher affinity towards Matriptase; have a very low, or nonmeasurable, immunogenicity in humans |
| 08/03/2006 | CA2593801A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/02/2006 | EP1686187A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 08/02/2006 | EP1686186A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 08/02/2006 | EP1686173A1 Genomically modified cell neutralized to serum-free system |
| 08/02/2006 | EP1686170A1 Novel brevibacillus choshinensis and process for producing protein with use of the microbe as host |
| 08/02/2006 | EP1686136A1 Novel glycoprotein and medicinal composition containing the same |
| 08/02/2006 | EP1685256A1 Method for flocculation of a fermentation broth comprising a fungus |
| 08/02/2006 | EP1685252A2 Use of cell lines to produce active therapeutic proteins |
| 08/02/2006 | EP1685245A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 08/02/2006 | EP1685240A2 Improved methods of in vitro protein synthesis |
| 08/02/2006 | EP1684801A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 08/02/2006 | EP1684790A2 Homogeneous preparations of chimeric proteins |
| 08/02/2006 | EP1684785A2 B cell-targeted toxins for humoral immune response reduction |
| 08/02/2006 | EP1381675B1 Method for replicating the hepatitis c virus |
| 08/02/2006 | EP1143800B1 Biological control of nematodes |
| 08/02/2006 | EP0996629B1 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0751962B1 Methods for inhibiting cd14 mediated cell activation |
| 08/02/2006 | EP0737208B1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 08/02/2006 | EP0686195B1 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria |
| 08/02/2006 | CN1813188A Diagnosis of carcinomas |
| 08/02/2006 | CN1813187A Nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 08/02/2006 | CN1810971A Antibacterial peptide gene of Chinese prawn containing single whey acidic protein structure domain and its coded antibacterial peptide and application |
| 08/02/2006 | CN1810969A Method of obtaining protein segment with independent structure/function |
| 08/02/2006 | CN1810954A Production process of human-alpha phylaxin-1 protein with colibacillus |
| 08/02/2006 | CN1810834A Process for preparing highly pure albumin solution |
| 08/02/2006 | CN1810832A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 08/02/2006 | CN1267562C Production of peptides by fedbatch cultivation of microoganism |
| 08/02/2006 | CN1267557C Genes for the synthesis of antipathogenic substances |
| 08/02/2006 | CN1267556C Method for increasing hemoprotein production in filamentous fungi |
| 08/02/2006 | CN1267553C Haemophilus transferrin receptor genes |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267453C Human erythropoietin Fc fusion protein with raised bioactivity |
| 08/02/2006 | CN1267452C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 08/02/2006 | CN1267448C Active peptide of pigeon |
| 08/01/2006 | US7084267 for the regulation of telomerase RNA genes, including the Sp family of transcription factors |
| 08/01/2006 | US7084259 G-protein coupled receptors |
| 08/01/2006 | US7084258 Antibodies against the PRO862 polypeptides |
| 08/01/2006 | US7084256 Plant extract; folded polypeptide |
| 08/01/2006 | US7084242 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol |
| 08/01/2006 | US7084239 stimulates cancer antigen specific cytotoxic T lymphocytes; useful in cancer diagnostics and immunotherapeutics including a cancer vaccine. |
| 08/01/2006 | US7084113 comprises a successfully elucidated crystal structure of a glycoprotein-binding protein originating from snake venom |
| 08/01/2006 | US7084105 Activating adenine triphosphate independent cytolytic modulator for use in the treatment of infection and cancer; generate nutrient broth, propagate microorganisms, allow microorganism to secrete protein, recover protein |
| 08/01/2006 | US7083979 Efficiency of transduction of hematopoietic cells; infecting cells in presence of fibronectin; stem cells; gene therapy |
| 08/01/2006 | US7083970 Comprises ribonuclease barnase marker gene; recombination/genetic engineering; libraries; drug resistance |
| 08/01/2006 | US7083966 Gene ecodeing protein; activation; cloning cloningDna libraries from rodents |
| 08/01/2006 | US7083962 Carbonyl reductases, polynucleotides comprising DNA encoding the same, methods for producing the same, and methods for producing optically active alcohol utilizing the same |
| 08/01/2006 | US7083960 Amino acid substitutions which result in reduced hydrophobicity; use in oxidizing the terminal methyl group of a substrate to a carboxylic acid |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083952 Nucleotide sequences coding phosphoserine phosphatase for generation of trangenic cornyeform bacterium with enhanced serine and threonine biosynthesis; for use in preparation of food, animal feeds and/or human therapeutics |
| 08/01/2006 | US7083950 Isolated nucleic acids; binding to immunoglobulins |
| 08/01/2006 | US7083949 Receptor based antagonists and methods of making and using |
| 08/01/2006 | US7083948 Polypeptide purification reagents and methods for their use |
| 08/01/2006 | US7083947 Assay techniques using nematode worms |
| 08/01/2006 | US7083946 Comprises nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cell proliferative, nervous system, autoimmune and cardiovascular disorders |
| 08/01/2006 | US7083945 Fusion proteins; labeled with fluorescence labels; screening libraries |
| 08/01/2006 | US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof |
| 08/01/2006 | US7083942 Alleles of the aceA gene from coryneform bacteria |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083938 Cell-based screening methods |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083931 Polypeptides; green fluorescent protein ; genetic engineering |
| 08/01/2006 | US7083930 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 08/01/2006 | US7083788 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | CA2265485C Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 08/01/2006 | CA2165435C Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 07/27/2006 | WO2006078821A2 Products and processes for in vitro synthesis of biomolecules |
| 07/27/2006 | WO2006078746A2 Method, compositions and classification for tumor diagnostics and treatment |
| 07/27/2006 | WO2006078645A2 Heterologous polypeptide expression using low multiplicity of infection of viruses |
| 07/27/2006 | WO2006078072A1 Non-human chimeric animal and use thereof |
| 07/27/2006 | WO2006078034A1 Cells capable of differentiating into cardiac muscle cells |
| 07/27/2006 | WO2006039622A3 Feeding buffers, systems, and methods for in vitro synthesis of biomolecules |
| 07/27/2006 | WO2006031327A3 Cloning and expression of recombinant adhesive protein mefp-2 of the blue mussel, mytilus edulis |
| 07/27/2006 | WO2006028497A3 Active recombinant human lysozyme |
| 07/27/2006 | WO2006014798A3 Methods and compositions for using sax2 |
| 07/27/2006 | WO2006013202A3 Conjugation of fvii |
| 07/27/2006 | WO2005123119A3 Administration of neutral endopeptidase to treat inflammatory bowel disease |
| 07/27/2006 | WO2005102038A3 Expression of polypeptides in rod outer segment membranes |
| 07/27/2006 | WO2005081904A3 Antimicrobial carbohydrates and methods of using same |
| 07/27/2006 | WO2004053081A3 Compositions, splice variants and methods relating to prostate specific genes and proteins |
| 07/27/2006 | US20060168687 Expression vector comprising nucleotide sequences coding acyl-CoA:lysophospholipid-acyltransferase for enhancing production of dihmo-gama-linolenic, arachidonic, eisosapentaenoic, docosapentaenoic acid and/or docosahexaenoic acids |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168668 Phosphodiesterase 2a and methods of use |
| 07/27/2006 | US20060167238 Gene expression using metal ion dependent repressor/operator tandems |
| 07/27/2006 | US20060167232 Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in blood |
| 07/27/2006 | US20060167231 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2006 | US20060167230 Anti-pci neutralizing antibody |